Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment – systematic review and modelling of progression and cost-effectiveness
Author(s) -
Andrew Farmer,
Richard Stevens,
Jennifer Hirst,
Thomas Lung,
Jason Oke,
Philip Clarke,
Paul Glasziou,
Andrew Neil,
David B. Dunger,
Helen M. Colhoun,
Christopher W. Pugh,
Germain Wong,
Rafael Perera,
Brian Shine
Publication year - 2014
Publication title -
health technology assessment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.426
H-Index - 126
eISSN - 2046-4924
pISSN - 1366-5278
DOI - 10.3310/hta18140
Subject(s) - medicine , microalbuminuria , kidney disease , renal function , meta analysis , diabetes mellitus , type 2 diabetes , intensive care medicine , systematic review , albuminuria , medline , endocrinology , political science , law
Annual screening for adults with type 2 diabetes to detect the early onset of kidney disease is widely recommended, but the recommendations are based on a limited methodological approach. In addition, there are continuing uncertainties about underlying rates of progression of the condition and the benefits of treatments with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom